First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Shows Promise Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(S2):1-3, January 20, 2020. Favorites PDF Get Content & Permissions Free
The Evolving Landscape of JAK Inhibition in the Treatment of Myelofibrosis Bose, Prithviraj; Verstovsek, Srdan Bose, Prithviraj; Verstovsek, Srdan Less Oncology Times. 42(S2):1,4-5, January 20, 2020. Favorites PDF Get Content & Permissions Free
Maintenance Therapy Improves Overall Survival in AML Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):8, January 20, 2020. Favorites PDF Get Content & Permissions Free
Blood Cancer Care Costs Skyrocket for Medicare Patients Hepp, Rebecca Hepp, Rebecca Less Oncology Times. 42(S2):9-10, January 20, 2020. Favorites PDF Get Content & Permissions Free
Advances in Multiple Myeloma: Updates from ASH 2019 Qazilbash, Muzaffar H. Qazilbash, Muzaffar H. Less Oncology Times. 42(S2):12-13, January 20, 2020. Favorites PDF Get Content & Permissions Free
Dual-Targeted Antibody Offers Positive Outcomes for Non-Hodgkin Lymphoma Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(S2):14, January 20, 2020. Favorites PDF Get Content & Permissions Free
What Is the Work Status of Young Adult Survivors Post-Transplant? Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(S2):15, January 20, 2020. Favorites PDF Get Content & Permissions Free
Novel Approach Provides Gene Therapy for Sickle Cell Disease Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):16, January 20, 2020. Favorites PDF Get Content & Permissions Free
Blinatumomab Improves Survival for Children with Relapsed B-ALL Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):17, January 20, 2020. Favorites PDF Get Content & Permissions Free
Experimental Drug Could Change Treatment for Rare Blood Disorder Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):18, January 20, 2020. Favorites PDF Get Content & Permissions Free
Driver Mutations Identified for AML & Myelodysplastic Syndrome Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):19, January 20, 2020. Favorites PDF Get Content & Permissions Free
Daratumumab Triple Combination Delays Disease Progression Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):20, January 20, 2020. Favorites PDF Get Content & Permissions Free
Socioeconomic Disparities Affect Survival of Children in AML Clinical Trials Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):21, January 20, 2020. Favorites PDF Get Content & Permissions Free
CAR T-Cell Therapy Shows Benefits for Older DLBCL Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):22, January 20, 2020. Favorites PDF Get Content & Permissions Free
Hands-On Approach Addresses Barriers to Care for DLBCL Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(S2):23, January 20, 2020. Favorites PDF Get Content & Permissions Free
Research Minute: Enhance Your Practice With the Latest Hematology/Oncology Research Less Oncology Times. 42(S2):24, January 20, 2020. Favorites PDF Get Content & Permissions Free
Discussing Technology's Impact on Cancer Care: Past, Present, & Future LaCorte, Sarah LaCorte, Sarah Less Oncology Times. 42(S2):6-7, January 20, 2020. Favorites PDF Get Content & Permissions Free
First Year of Fellowship: Acclimating to the Work LaCorte, Sarah LaCorte, Sarah Less Oncology Times. 42(S2):11,13, January 20, 2020. Favorites PDF Get Content & Permissions Free
